Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Asia Virtual Congress 2020: Industry Sponsored Satellite Symposia - Immunotherapy

ESMO-Asia-2020-Virtual-1000x250

Immunotherapy

Improving Outcomes with Immuno-Oncology: Evolving Treatment Paradigms for First-Line ES-SCLC and Unresectable Stage III NSCLC

01-Improving-Outcomes-with-Immuno-Oncology-ASTRAZENECA-Thumb

Friday, 20 November, 12:00-13:30 (SGT)
View the satellite invitation

Extending Longer-Term Survival in Lung Cancer and HNSCC with IO and Novel Combinations

03-EXT~1

Friday, 20 November, 12:00-13:30 (SGT)
View the satellite invitation

Emerging Immuno-Oncology Combinations for The Treatment Of HCC

09-Emerging-Immuno-Oncology-Combinations-for-The-Treatment-Of-HCC-ASTRAZENECA-Thumbs

Saturday, 21 November, 12:00-13:30 (SGT)
View the satellite invitation

Getting Ahead in SCCHN: Dynamic Treatment Options with Cetuximab

20-Getting-Ahead-in-SCCHN-Dynamic-Treatment-Options-with-Cetuximab-MERCK-Thumb

Sunday, 22 November, 12:00-13:30 (SGT)
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Asia Virtual Congress 2020 Industry Sponsored Satellite Symposia Programme